Qu Biologics
Burnaby · 2 known investors
Find your way into Qu Biologics
15 people in our graph share verified history with the Qu Biologics team — schools, employers, funds. One of them is your warm intro.
Ossama Hassaneinunlockedknows Hal Gunn · together at University of British Columbia (overlapped)
knows the team · via Qu Biologics
×10knows the team · via University of British Columbia
Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
Founders & leadership
HG
SS
Simon SutcliffeChief Medical Officer
AR
Alun ReesNamed on SEC filing
RE
Robert E. PelzerNamed on SEC filing
ML
Michael LeschukNamed on SEC filing
GV
Gillian VandermeirschNamed on SEC filing
JP
Jim PankovichNamed on SEC filing
JL
Julia LevyNamed on SEC filing
Investors · 2
Funding
SEC filings, press & company announcements$12M disclosed across 2 rounds · 2018–2022
- $12MraisedMar 2022 · 2 sourcesSource ↗
▶$48.8KraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$48.8KraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Simon SutcliffeExecutive Officer, Director
- Alun ReesExecutive Officer
- Robert E. PelzerDirector
- Michael LeschukDirector
- Harold David GunnExecutive Officer, Director
- Gillian VandermeirschExecutive Officer
- Jim PankovichExecutive Officer
- Julia LevyDirector
- Offering amount
- $77.6K
- Amount sold
- $48.8K
- First sale
- May 2018
- Incorporated
- Corporation, British Columbia, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
IQVIA26 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Q32 Bio19 shared keywordsQ32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.
Q Bio, Inc.12 shared keywordsQ.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.
Companies competing with Qu Biologics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Qu Biologics do?
- Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
- Who founded Qu Biologics?
- Qu Biologics was founded by Hal Gunn.
- Who are Qu Biologics's investors?
- Qu Biologics's investors include Curitas Ventures, Harmonix Fund.
- How much funding has Qu Biologics raised?
- Qu Biologics has disclosed $12M raised across 2 rounds.
- Where is Qu Biologics headquartered?
- Qu Biologics is headquartered in Burnaby.